Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2008 2
2009 5
2010 7
2011 13
2012 14
2013 13
2014 29
2015 15
2016 20
2017 21
2018 20
2019 14
2020 19
2021 21
2022 14
2023 23
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Targeted therapy in glomerular diseases.
Lin YC, Gau TS, Jiang ZH, Chen KY, Tsai YT, Lin KY, Tung HN, Chang FC. Lin YC, et al. Among authors: tsai yt. J Formos Med Assoc. 2024 Feb;123(2):149-158. doi: 10.1016/j.jfma.2023.06.020. Epub 2023 Jul 11. J Formos Med Assoc. 2024. PMID: 37442744 Free article. Review.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Prime Editing for Inherited Retinal Diseases.
da Costa BL, Levi SR, Eulau E, Tsai YT, Quinn PMJ. da Costa BL, et al. Among authors: tsai yt. Front Genome Ed. 2021 Nov 25;3:775330. doi: 10.3389/fgeed.2021.775330. eCollection 2021. Front Genome Ed. 2021. PMID: 34901928 Free PMC article. Review.
Effusive Tuberculous Pericarditis.
Zheng XZ, Tsai YT, Lin CY, Tsai CS, Lin YC. Zheng XZ, et al. Among authors: tsai yt. Ann Thorac Surg. 2017 Nov;104(5):e397. doi: 10.1016/j.athoracsur.2017.07.010. Ann Thorac Surg. 2017. PMID: 29054238 No abstract available.
Rod metabolic demand drives progression in retinopathies.
Lin MK, Kim SH, Zhang L, Tsai YT, Tsang SH. Lin MK, et al. Among authors: tsai yt. Taiwan J Ophthalmol. 2015 Jul-Sep;5(3):105-108. doi: 10.1016/j.tjo.2015.06.002. Epub 2015 Aug 25. Taiwan J Ophthalmol. 2015. PMID: 29018679 Free PMC article. Review.
Gene and cell-based therapies for inherited retinal disorders: An update.
Sengillo JD, Justus S, Tsai YT, Cabral T, Tsang SH. Sengillo JD, et al. Among authors: tsai yt. Am J Med Genet C Semin Med Genet. 2016 Dec;172(4):349-366. doi: 10.1002/ajmg.c.31534. Epub 2016 Nov 8. Am J Med Genet C Semin Med Genet. 2016. PMID: 27862925 Free PMC article. Review.
234 results